Another possibility may be that, acting via an as yet unknown mechanism, the APOE4 genotype may affect the activity of the BNP metabolising enzymes, including neprilysin and insulin degrading enzyme [50], which have also been demonstrated to regulate the metabolism of the amyloid β peptide, one of key molecules involved in the pathology of AD [51]. This evidence concerns the gene NPPB and Alzheimer disease.